par Berghmans, Thierry 
;Lafitte, Jean-Jacques;Scherpereel, Arnaud;Paesmans, Marianne ;Lecomte, Jacques;Marco, Vicente Giner;Meert, Anne-Pascale ;Leclercq, Nathalie ;Sculier, Jean-Paul ;European Lung Cancer Working Party,
Référence Anticancer research, 33, 12, page (5477-5482)
Publication Publié, 2013-12
;Lafitte, Jean-Jacques;Scherpereel, Arnaud;Paesmans, Marianne ;Lecomte, Jacques;Marco, Vicente Giner;Meert, Anne-Pascale ;Leclercq, Nathalie ;Sculier, Jean-Paul ;European Lung Cancer Working Party, Référence Anticancer research, 33, 12, page (5477-5482)
Publication Publié, 2013-12
Article révisé par les pairs
| Titre: |
|
| Auteur: | Berghmans, Thierry; Lafitte, Jean-Jacques; Scherpereel, Arnaud; Paesmans, Marianne; Lecomte, Jacques; Marco, Vicente Giner; Meert, Anne-Pascale; Leclercq, Nathalie; Sculier, Jean-Paul; European Lung Cancer Working Party, |
| Informations sur la publication: | Anticancer research, 33, 12, page (5477-5482) |
| Statut de publication: | Publié, 2013-12 |
| Sujet CREF: | Sciences bio-médicales et agricoles |
| Mots-clés: | Cisplatin |
| Docetaxel | |
| Ifosfamide | |
| Non-small cell lung cancer | |
| Phase III trial | |
| Survival | |
| MeSH keywords: | Adult |
| Aged | |
| Aged, 80 and over | |
| Antineoplastic Combined Chemotherapy Protocols -- therapeutic use | |
| Carcinoma, Non-Small-Cell Lung -- drug therapy | |
| Cisplatin -- administration & dosage -- therapeutic use | |
| Female | |
| Humans | |
| Ifosfamide -- administration & dosage -- therapeutic use | |
| Lung Neoplasms -- drug therapy | |
| Male | |
| Middle Aged | |
| Survival Analysis | |
| Note générale: | Journal Article |
| SCOPUS: ar.j | |
| Langue: | Anglais |
| Identificateurs: | urn:issn:0250-7005 |
| info:pii/33/12/5477 | |
| info:scp/84891423995 | |
| info:pmid/24324084 |
